Table 1.
PSG parameter | Testing conditions | ||||
---|---|---|---|---|---|
Initial diagnostic PSGa | Initial CPAP titration |
Optimal CPAP+ acetazolamideb |
Follow-upc | ||
Obstructive AHI, no./h | 27 | 12 | 0 | 0 | |
CAI, no./h | 7 | 66 | 1 | 17 | |
Total AHI | 34 | 78 | 1 | 17 | |
RERA index, no./h | 7 | 0 | 4 | 0 | |
RDI, no./h | 41 | 78 | 5 | 17 | |
Percentage of sleep time with SaO2 less than | |||||
90% | 88 | 57 | 0 | 0.1 | |
85% | 5 | 6 | 0 | 0 | |
Mean SaO2, % | 88 | 89 | 94 | 94 | |
Lowest O2 value, % | 78 | 74 | 93 | 82 | |
AI, no./hd | 18 | 0 | 1 | 0 |
Duration of baseline polysomnography (PSG) was 140 minutes.
Optimal continuous positive airway pressure (CPAP), 9 cm h2o, and acetazolamide, 250 mg, at bedtime for 7 days.
Five-month follow-up on CPAP without acetazolamide (off acetazolamide for 7 days).
Number of arousals per hour of sleep not related to respiratory events.
Abbreviations: AHI, apnea-hypopnea index; CAI, central apnea index; RERA, respiratory event-related arousals; RDI, respiratory disturbance index.